Here are the 10-Q quarterly reports from Nature's Mircle Holding WTS (NMHIW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NMHIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NMHIW filings page.
Nature’s Miracle Holding Inc. reported a challenging quarter ended March 31, 2026. Revenue fell sharply to $41,605 from $1,106,819 a year earlier, producing gross profit of only $2,920 and an operating loss of $1,087,864.
Despite this, the company posted net income of $2,845,274, largely from a non-recurring $5,070,520 gain on debt settlement and a favorable change in fair value of commitment shares. Cash and cash equivalents were $45,695, with a working capital deficit of about $17.6M and total liabilities of $29.3M exceeding assets of $21.5M, leaving stockholders’ deficit at roughly $9.3M.
Management discloses recurring operating losses, negative operating cash flow of about $1.6M, heavy use of short-term and convertible debt, and substantial dilution, as common shares outstanding rose to 308,306,016 from 112,852,596. These factors led to a conclusion that substantial doubt exists about the company’s ability to continue as a going concern, even though it has a $20M equity line and a related-party $2M convertible note facility available for additional financing.
Nature’s Miracle Holding Inc. filed an amended quarterly report to restate its unaudited financial statements for the three and nine months ended September 30, 2025 after identifying an unrecorded $1.65 million short‑term loan at newly acquired Zak Properties.
The restatement increases short‑term loans and total liabilities and reduces additional paid‑in capital, deepening the stockholders’ deficit to $(9.36) million. For the nine months, the company generated revenue of $1.66 million and recorded a net loss of $5.99 million, with cash of only $61,450 and a working capital deficit of about $19.7 million.
Management concludes that recurring losses, negative operating cash flow and large deficits raise substantial doubt about Nature’s Miracle’s ability to continue as a going concern. The company cites material weaknesses in internal control over financial reporting, particularly around due diligence for acquisitions, and plans enhanced reconciliation and review controls.